Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways
Authors
Keywords
Airway hyperresponsiveness, Asthma, Inflammation, LABA/ICS, Synergy, LABA/LAMA/ICS
Journal
PHARMACOLOGICAL RESEARCH
Volume 172, Issue -, Pages 105801
Publisher
Elsevier BV
Online
2021-08-05
DOI
10.1016/j.phrs.2021.105801
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)
- (2020) Christian Gessner et al. RESPIRATORY MEDICINE
- Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study
- (2020) Richard N van Zyl-Smit et al. Lancet Respiratory Medicine
- Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study
- (2020) Huib A M Kerstjens et al. Lancet Respiratory Medicine
- Minimal clinically important difference for asthma endpoints: an expert consensus report
- (2020) Matteo Bonini et al. European Respiratory Review
- Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings
- (2020) Paola Rogliani et al. Expert Review of Clinical Pharmacology
- The Cytokines of Asthma
- (2019) Bart N. Lambrecht et al. IMMUNITY
- Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: synergy of triple combination therapy on human airway smooth muscle ex vivo
- (2019) Paola Rogliani et al. BRITISH JOURNAL OF PHARMACOLOGY
- Psychological Stress, Lung Function and Exacerbation Risk in COPD: Is an Increase of Cholinergic Tone a Possible Link?
- (2018) Gennaro Liccardi et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Pharmacological mechanisms leading to synergy in fixed-dose dual bronchodilator therapy
- (2018) Luigino Calzetta et al. CURRENT OPINION IN PHARMACOLOGY
- After asthma: redefining airways diseases
- (2018) Ian D Pavord et al. LANCET
- Anxiety and asthma in youth. Is a stress-induced increased cholinergic tone the possible link?
- (2017) Gennaro Liccardi et al. PEDIATRIC PULMONOLOGY
- Interaction between corticosteroids and muscarinic antagonists in human airways
- (2016) Mario Cazzola et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics
- (2016) Gennaro Liccardi et al. RESPIRATORY MEDICINE
- The use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics
- (2016) Alida Benfante et al. Therapeutics and Clinical Risk Management
- Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma?
- (2016) Gennaro Liccardi et al. Journal of Allergy and Clinical Immunology-In Practice
- Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi
- (2015) Paola Rogliani et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Non-neuronal cholinergic airway epithelium biology
- (2014) Wolfgang Kummer et al. CURRENT OPINION IN PHARMACOLOGY
- A new perspective on muscarinic receptor antagonism in obstructive airways diseases
- (2013) Herman Meurs et al. CURRENT OPINION IN PHARMACOLOGY
- The influence of propofol, remifentanil and lidocaine on the tone of human bronchial smooth muscle
- (2013) Paola Rogliani et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Influences of Smoking and Aging on Allergic Airway Inflammation in Asthma
- (2013) Tadao Nagasaki et al. ALLERGOLOGY INTERNATIONAL
- Asthma outcomes revisited
- (2012) Amit D. Parulekar et al. CURRENT OPINION IN PULMONARY MEDICINE
- Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity
- (2012) Maria G. Matera et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Pharmacological Characterization of Adenosine Receptors on Isolated Human Bronchi
- (2011) Luigino Calzetta et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Protein Prenylation Contributes to the Effects of LPS on EFS–Induced Responses in Human Isolated Bronchi
- (2011) Mario Cazzola et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi
- (2011) Maria G. Matera et al. BRITISH JOURNAL OF PHARMACOLOGY
- Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi
- (2011) Maria G. Matera et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Dual bronchodilatory and pulmonary anti-inflammatory activity of RO5024118, a novel agonist at vasoactive intestinal peptide VPAC2 receptors
- (2010) SA Tannu et al. BRITISH JOURNAL OF PHARMACOLOGY
- The definition and diagnosis of Asthma
- (2009) F. E. Hargreave et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi
- (2009) Maria Gabriella Matera et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now